Jeffrey Merling
Family Medicine · Cincinnati, OHNPI 1366434391
Payments from drug & device makers
Across 280 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$623
- Pfizer$573
- AstraZeneca$551
- Novo Nordisk$370
- Lilly USA, LLC$227
- GSK$227
- plus $2K from 34 others
What the payments were for
- Food & beverage$4,507100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $623 |
| Pfizer | 53 | $573 |
| AstraZeneca | 14 | $551 |
| Novo Nordisk | 25 | $370 |
| Lilly USA, LLC | 11 | $227 |
| GSK | 15 | $227 |
| Merck | 15 | $209 |
| Amgen | 9 | $147 |
| Johnson & Johnson | 9 | $127 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Abbott | 6 | $122 |
| Astellas Pharma US Inc | 8 | $116 |
| Boehringer Ingelheim | 8 | $114 |
| Daiichi Sankyo Inc. | 7 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $99 |
| Biohaven Pharmaceuticals, Inc. | 6 | $99 |
| Amarin Pharma, Inc. | 5 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $67 |
| Bayer | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 4 | $52 |
| Hikma Pharmaceuticals USA | 3 | $39 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Dexcom, Inc. | 2 | $34 |
| Exact Sciences | 2 | $32 |
| Corium, LLC | 2 | $32 |
| Novartis | 2 | $29 |
| Ironshore Pharmaceuticals Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 2 | $24 |
| Currax Pharmaceuticals LLC | 2 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Vivus LLC | 1 | $17 |
| Kaleo, Inc. | 1 | $14 |
| Neos Therapeutics, LP | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| MDD US Operations, LLC | 1 | $13 |
| Dermira, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,507 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Solifenacin Succinate | 15 | $301 |
| Losartan Potassium | 18 | $172 |
| Tamsulosin Hcl | 12 | $139 |
| Levothyroxine Sodium | 14 | $107 |
| Atorvastatin Calcium | 13 | $93 |
| Simvastatin | 12 | $85 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Cincinnati
- Michael ButcherCincinnati$18.3M
- Paul NugentCincinnati$4.9M
- Rajesh DavitCincinnati$2M
- Michael HeileCincinnati$272K
- Michael NossCincinnati$265K
- Amy MechleyCincinnati$120K
- Melissa SchroerCincinnati$116K
- William CoxCincinnati$52K
- Frank PerrinoCincinnati$49K
- Sean LyndCincinnati$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.